%D8%A8%D9%8A%D8%AA%D8%B1_%D8%A8%D9%88%D9%8A%D9%84_(%D8%A5%D8%AD%D8%B5%D8%A7%D8%A6%D9%8A)%D9%BE%DB%8C%D8%AA%D8%B1_%D8%A8%D9%88%DB%8C%D9%84_(%D8%A7%D9%BE%DB%8C%D8%AF%D9%85%DB%8C%D9%88%D9%84%D9%88%DA%98%DB%8C%D8%B3%D8%AA)Peter_Boyle_(Epidemiologe)Peter_Boyle_(epidemiologist)%D9%BE%DB%8C%D8%AA%D8%B1_%D8%A8%D9%88%DB%8C%D9%84_(%D8%A7%D9%BE%DB%8C%D8%AF%D9%85%DB%8C%D9%88%D9%84%D9%88%DA%98%DB%8C%D8%B3%D8%AA)Peter_Boyle_(%C3%A9pid%C3%A9miologiste)Q2074086
about
Sexual factors and prostate cancerCutaneous melanoma attributable to sunbed use: systematic review and meta-analysisMaps and atlases of cancer mortality: a review of a useful tool to trigger new questionsEradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issueAn assessment of the barriers to accessing the Basic Package of Health Services (BPHS) in Afghanistan: was the BPHS a success?Effects of Environmental Exposures on Fetal and Childhood Growth TrajectoriesDistribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative studyPrior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States womenAndrogenetic alopecia in men aged 40-69 years: prevalence and risk factorsELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancerTobacco smoking and the British doctors' cohortCigarette smoking, alcohol, tea and coffee consumption and pancreas cancer risk: a case-control study from Opole, PolandLifetime consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: a population-based case-control study in The NetherlandsTamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyTobacco industry must not dump its high nitrosamine tobacco on poor countriesGenetic variation in metabolic genes, occupational solvent exposure, and risk of non-hodgkin lymphomaOccupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut womenEstimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accidentChanging global policy to deliver safe, equitable, and affordable care for women's cancers.Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseCancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.A case-control study of lung cancer among Czech women.Analysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects?Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method.Alcohol consumption and breast cancer riskEpidemiology of prostate cancer chemoprevention.Marital status, indicators of sexual activity and prostatic cancer.Gastrectomy and subsequent risk of oesophageal cancer in MilanCancer in patients on dialysis for end-stage renal disease: an international collaborative study.GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaMeta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.European Code Against Cancer and scientific justification: third version (2003).The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.The causes of cancer in France.Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.Diet and breast cancer: a case-control study in Greece.Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphomaMouthwash and oral cancer risk quantitative meta-analysis of epidemiologic studies.Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
P50
Q21999082-D491178B-28E5-4FEF-A991-9CB897779C3DQ24629925-B7B5047C-941A-46A9-8E32-C0E017BAD8B9Q28072699-955CD3F5-4B74-45D3-BE6B-508D862027CCQ28077094-90D4D2CA-67C1-4DF2-A703-E62D76A2D9F9Q28077498-D683A838-2D18-4BE2-9FCE-047A559D602BQ28079540-531D3E10-DA8D-4157-8E44-8A3C33E3E11DQ28141871-95C107E3-C68B-4F57-9028-CEBBE3E84978Q28168608-7D5107F9-F3A7-46E7-BA3D-569BB2A63014Q28191418-8081F775-D2A4-430B-8444-507B89476E4AQ28208394-C4DBA0CD-2350-41D8-B99F-E01569717AB8Q28217575-0A251C39-FE33-4D41-A1DB-3B57BF7BFF21Q28266375-5E34E83F-1037-4FF1-BEF3-78FC1D7E8427Q28282870-6DF3026F-0726-419C-BEAD-371E0A215B25Q28300092-2AFF2957-74B7-48D9-A403-DE43BA5EAB75Q28354389-BF8F31E9-1111-4779-BA06-5C322BCE2003Q28386043-FCB9AE32-B204-4F06-8B81-487824082525Q28390365-97AC2982-A55F-450A-A650-EB9EEEBCEB34Q29037836-8C592BD9-2644-47F8-82A7-461D3296369EQ30241794-938E03A2-42AC-4A0D-A5AA-8F4D62F686FAQ30747351-399BD699-D6D6-4D29-9614-C4EAD04F1EF3Q30758525-5B430A5F-6339-430E-9D90-FD27E53D389CQ31878592-7CDA10EF-F869-4639-B86F-BBF925AD337EQ33422404-EB638124-019A-4BA7-A337-EC13F41722CAQ33551799-28484CB2-F31A-4FC8-B072-9409426F11FAQ33555456-368FE987-9368-4805-BBF0-C1520F4FFD1DQ33633895-58FE0CE1-7B8B-45A9-891C-53704AD23FBEQ33702085-A9002338-4A9B-4129-85EF-B4B2C5789AD6Q33702478-30578333-F1AD-42EA-ACC2-7A338DF489FFQ33845510-A9B35030-10AB-47A7-939E-EF604584C167Q33886166-0DBA81F8-DDE4-4704-A70F-45F3D788183FQ33895865-47C6ACFB-AFEF-41A9-8DD7-C9CDF59E5363Q33961645-AFD5DCF5-86FE-4188-AAF3-BD1C104E7349Q33967068-DE2FE746-8E44-4AEA-999B-E058DACDB9A7Q33967881-BB2C4FB8-617C-41A3-B742-AAABB16D8984Q34013618-14268765-6D54-42A8-A846-9DA2C12D6727Q34033939-58217CE1-745D-4BF7-B781-BE6E16E6CD90Q34190814-7F116005-2834-4EE9-9746-FF858273BCAFQ34273265-06DBCC3E-177C-49CE-8139-305DABD4B316Q34284764-F660B0DA-CE8D-442A-9224-506816AFEBC5Q34309375-1C795D48-69A0-42F7-89C2-A37DC45F12A0
P50
subject
description
British epidemiologist
@en
Brits epidemioloog
@nl
schottischer Epidemiologe und Statistiker
@de
épidémiologiste britannique
@fr
name
Peter Boyle
@ast
Peter Boyle
@ca
Peter Boyle
@de
Peter Boyle
@en
Peter Boyle
@es
Peter Boyle
@fr
Peter Boyle
@hu
Peter Boyle
@it
Peter Boyle
@nl
Peter Boyle
@sl
type
label
Peter Boyle
@ast
Peter Boyle
@ca
Peter Boyle
@de
Peter Boyle
@en
Peter Boyle
@es
Peter Boyle
@fr
Peter Boyle
@hu
Peter Boyle
@it
Peter Boyle
@nl
Peter Boyle
@sl
prefLabel
Peter Boyle
@ast
Peter Boyle
@ca
Peter Boyle
@de
Peter Boyle
@en
Peter Boyle
@es
Peter Boyle
@fr
Peter Boyle
@hu
Peter Boyle
@it
Peter Boyle
@nl
Peter Boyle
@sl
P108
P166
P463
P1006
P1015
P214
P244
P268
P269
P1006
P101
P1015
P1053
A-4380-2014
P1153
26643526600
P1207
n2008039255